As expected and as previously reported by our research group [19], a positive correlation between MVD and SRSF1 immunoexpression was found: in particular, GBM cases with high SRSF1 immunohistochemical expression (IRS ≥ 6) exhibited higher MVD values than those with SRSF1 IRS < 6 (median values: 114/mm2 vs. 67/mm2) (Figure 8A,B). This evidence concerns the gene SRSF1 and glioblastoma.